O/M items only: blood/blood products, biological materials, chemicals

Ended Blanket Purchase Agreement Awarded Last action

Contract number
HHSN263200000053546B
Awardee
Awarding agency
Task orders
3 $28,629 obligated

Award facts

Combined order value
  • $28,629 Current, with exercised options
  • $43,536 Potential, with all options
Last date to order 100% complete
Maximum order
$25,000.00
Who can order
Only the awarding agency
NAICS code
Not on record
Set-aside
No set-aside
Competition
Not Competed Simplified Acquisition
Pricing
Order Dependent (IDV only)

Award details come from SAM.gov/FPDS.

About this IDV

Written by GovTribe AI ·

This Blanket Purchase Agreement (BPA) was awarded by the Department of Health and Human Services (HHS), National Institutes of Health (NIH), to MBL International Corporation, a for-profit manufacturer of goods. The BPA covers the procurement of blood/blood products, biological materials, and chemicals. The BPA has no set-aside and was originally awarded on July 11, 2002, with an open-ended potential value.

Under this BPA, three task orders have been issued to date. The first, awarded on December 18, 2013, was a firm fixed-price BPA call for $26,680.50 to procure an APC-H-2 DB RSV product. The second, awarded on December 3, 2010, was a fixed-price with economic price adjustment BPA call for $16,855.72 to procure an H2A.X phosphorylation ELISA kit. The third, awarded on November 3, 2009, was a BPA call of unspecified pricing type for recombinant mouse IL-18. All task orders were performed in Bethesda, MD. The BPA had an original ordering period that ran through June 30, 2015.

Task orders

Task order Ordering agency Obligated Awarded
Ambis# 1657293 - APC-H-2 DB RSV, product# T03035, sequence naitnakii, QTY 3 @ $1,260.00/each HHSN27200003 NIAID DEA OA Acquisitions (NIH) $6,584
H2A.X phosphorylation elisa kit CY-1143 HHSN26100001 National Cancer Institute (NIH) $16,856
Ambis# 927362RECOMBINANT mouse IL-18, 200UG HHSN27200002 NIAID DEA OA Acquisitions (NIH) $5,189

Transactions

Action Obligated Date
Other Administrative Action 16 $0
Other Administrative Action 15 $0
Other Administrative Action 14 $0
Other Administrative Action 13 $0
Other Administrative Action 12 $0
Other Administrative Action 11 $0
Other Administrative Action 10 $0
Other Administrative Action 9 $0
Other Administrative Action 8 · Biological materials $0
Vendor DUNS or Name Change - Non-Novation 7 $0
Other Administrative Action 6 $0
Other Administrative Action 5 $0
Other Administrative Action 4 · Blood/blood products, biological materials, chemicals $0
Other Administrative Action 3 $0
Other Administrative Action 2 $0
Other Administrative Action 1 $0
Original award $0
Show all 17

Quick answers

Who was awarded contract HHSN263200000053546B?

HHSN263200000053546B was awarded to MBL International Corporation by Office of the Director (National Institutes of Health) on July 11, 2002.

How much is contract HHSN263200000053546B worth?

Orders under HHSN263200000053546B have obligated $28,629. Their combined potential value, with all options, is $43,536. A single order can be worth up to $25,000.

How many orders have been placed under contract HHSN263200000053546B?

3 orders have been placed under HHSN263200000053546B, the latest on December 18, 2013.

Who can order from contract HHSN263200000053546B?

Only the awarding agency can place orders on it.

Was contract HHSN263200000053546B competed?

The extent of competition for HHSN263200000053546B was not competed.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV
Try for free Login